Relmada Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Relmada Therapeutics, Inc. - overview
Established
2004
Location
New York, NY, US
Primary Industry
Pharmaceuticals
About
Founded in 2004 and based in New York, US, Relmada Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company that develops orally-administered medications for chronic pain associated with depression, central nervous system, and ophthalmic disorders.
Current Investors
Ben Franklin Technology Partners, BioAdvance
Primary Industry
Pharmaceuticals
Sub Industries
Biotechnology, Specialty Pharmaceuticals, Pharmaceutical Research & Development
Website
www.relmada.com
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.